We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
+5.54%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$173M
AUM Growth
+$73.3M
Cap. Flow
+$11.6M
Cap. Flow %
6.67%
Top 10 Hldgs %
96.13%
Holding
83
New
26
Increased
11
Reduced
13
Closed
29

Top Buys

Rank Stock Value
1
VANI icon
Vivani Medical
VANI
+$3.94M
2
FMTO
Femto Technologies Inc. Common Stock
FMTO
+$2.65M
3
ELTK icon
Eltek
ELTK
+$1.68M
4
RDHL
Redhill Biopharma
RDHL
+$1.65M
5
GMM icon
Global Mofy Metaverse
GMM
+$1.57M

Top Sells

Rank Stock Value
1
MMAT
Meta Materials Inc. Common Stock
MMAT
+$904K
2
PHUN icon
Phunware
PHUN
+$821K
3
CYN icon
Cyngn
CYN
+$507K
4
TGL icon
Treasure Global
TGL
+$426K
5
DUO
Fangdd Network Group
DUO
+$392K

Sector Composition

Rank Sector Weight
1 Healthcare 5.65%
2 Technology 1.24%
3 Materials 0.46%
4 Industrials 0.37%
5 Energy 0.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BJDX icon
26
Bluejay Diagnostics
BJDX
$1.03M
$150K 0.09%
117
+23
+24% +$31.7K
INM icon
27
InMed Pharmaceuticals
INM
$8.92M
$132K 0.08%
18,086
-7,511
-29% -$55.2K
SCNI
28
Scinai Immunotherapeutics
SCNI
$1.36M
$131K 0.08%
25,314
+3,248
+15% +$16.8K
FMTO
29
DELISTED
Femto Technologies Inc. Common Stock
FMTO
$129K 0.07%
11
+9
+450% +$2.65M
PCSA icon
30
Processa Pharmaceuticals
PCSA
$8.44M
$115K 0.07%
+1,944
New +$154K
BCTX
31
PUT
Briacell Therapeutics
BCTX
$30.2M
$99.8K 0.06%
2
– –
ATXI
32
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
$99K 0.06%
+8,946
New +$106K
BCTX
33
Briacell Therapeutics
BCTX
$30.2M
$97.9K 0.06%
+228
New +$126K
AKTX
34
Akari Therapeutics
AKTX
$14.8M
$90.4K 0.05%
1,212
-2,889
-70% -$279K
RKDA icon
35
Arcadia Biosciences
RKDA
$1.37M
$89.1K 0.05%
40,300
-57,005
-59% -$148K
AZTR icon
36
Azitra
AZTR
$2.11M
$87.4K 0.05%
+2,128
New +$309K
RVPH
37
PUT
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
$81.3K 0.05%
+11
New +$872
IBIO icon
38
iBio
IBIO
$69.1M
$56.8K 0.03%
14,000
-162,748
-92% -$205K
AMPGW
39
DELISTED
Amplitech Group Warrants
AMPGW
$55K 0.03%
379,044
-31,176
-8% -$4.22K
EOSE icon
40
PUT
Eos Energy Enterprises
EOSE
$1.22B
$52.5K 0.03%
510
+410
+410% +$417
CORZZ icon
41
Core Scientific Inc Tranche 2 Warrants
CORZZ
$1.72B
$34.8K 0.02%
+14,497
New +$35.7K
WLDSW icon
42
Wearable Devices Ltd Warrant
WLDSW
$135K
$29.3K 0.02%
507
-436
-46% -$23.5K
GEVO icon
43
CALL
Gevo
GEVO
$363M
$25.3K 0.01%
329
-1,346
-80% -$1.17K
SXTPW icon
44
60 Degrees Pharmaceuticals Warrant
SXTPW
$23.3K 0.01%
306,717
– –
IVF
45
INVO Fertility Inc
IVF
$1.75M
$21K 0.01%
13
– –
SPCB icon
46
SuperCom
SPCB
$65.9M
$20.2K 0.01%
+6,089
New +$26.2K
SPIR icon
47
Spire Global
SPIR
$440M
$18.2K 0.01%
+1,518
New +$15.1K
CINGW icon
48
Cingulate Inc Warrants
CINGW
$59.3K
$7.08K ﹤0.01%
468,722
-90,494
-16% -$1.77K
TC
49
TuanChe
TC
$61M
$6.44K ﹤0.01%
209
-5,480
-96% -$235K
CNEY icon
50
CN Energy Group
CNEY
$4.85M
$5.3K ﹤0.01%
+200
New +$6.97K
1
2
3 4

Similar funds

CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
CTC
Corundum Trust Company Sioux Falls, South Dakota $43.8M AUM 20.07% 1-Year Est. Return

Sabby Management's Q1 2024 Portfolio in Review

As of Q1 2024, Sabby Management held 83 positions worth $173M, up 73% from $100M the previous quarter. Its ten largest holdings account for 96% of the portfolio.

Sabby Management deployed $11.6M of net new capital in Q1 2024, opening 26 new positions and adding to 11 existing holdings. Its largest new stake was Vivani Medical: 2,673,018 shares worth $4.95M.

By sector, the portfolio is most concentrated in Healthcare at 5.6% of assets, up from 3.8% a quarter earlier, followed by Technology and Materials.

On the sell side, the largest reduction was Akari Therapeutics, an estimated $279K trimmed.

  • Sabby Management's largest Q1 2024 buy was Vivani Medical: 2,673,018 shares worth $4.95M.
  • Sabby Management added most to Femto Technologies Inc. Common Stock in Q1 2024, an estimated $2.65M increase.
  • Sabby Management's biggest Q1 2024 reduction was Akari Therapeutics, cutting an estimated $279K.
  • Sabby Management fully exited Meta Materials Inc. Common Stock in Q1 2024, selling an estimated $904K.
  • Sabby Management's ten largest holdings make up 96% of its $173M portfolio in Q1 2024.
  • Sabby Management opened 26 new positions and closed 29 in Q1 2024.
  • Sabby Management's portfolio value rose 73% quarter-over-quarter to $173M.

Based on Sabby Management's 13F filing for Q1 2024, filed 15 May 2024.